Skip to main content
. Author manuscript; available in PMC: 2017 Oct 25.
Published in final edited form as: Clin Breast Cancer. 2012 Apr;12(2):81–86. doi: 10.1016/j.clbc.2012.01.001

Table 2.

Patients’ Prior Treatment History

Prior Treatments No. (%) of Patients (N=46)a
Prior chemotherapy
    Yes 14 (30.4)
    No 32 (69.6)
Prior anthracycline
    Neoadjuvant 10 (21.7)
    Adjuvant 30 (65.2)
    Metastatic 1 (2.2)
    None 5 (10.9)
Prior trastuzumab
    Neoadjuvant 3 (6.5)
    Adjuvant 10 (21.7)
    Metastatic 13 (28.3)
    None 20 (43.5)
Prior taxane
    Neoadjuvant 6 (13.0)
    Adjuvant 25 (54.3)
    Metastatic 9 (19.6)
    None 6 (13.0)
a

Percentages may not total 100% due to rounding.